ARASH MILANI: Open Payments
NPI 1043581317 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,514 in 108 payments from 29 companies in 2025. Trend: 2023 $2,966 · 2024 $2,697 · 2025 $2,514
Food & beverage: $2,514
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $324 |
| AstraZeneca Pharmaceuticals LP | 12 | $270 |
| Amgen Inc. | 6 | $214 |
| Otsuka America Pharmaceutical, Inc. | 9 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $138 |
| Biogen, Inc. | 1 | $120 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Baxter Healthcare | 4 | $101 |
| Viatris Specialty LLC | 4 | $94 |
Products named: REXULTI, KRYSTEXXA, CAPLYTA, NURTEC ODT, VYNDAQEL, Kerendia, AIRSUPRA, SKYCLARYS.
Industry payments across CA — which companies pay providers there.
